HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Flavell Selected Research

Richard Flavell Research Topics

Disease

7Inflammation (Inflammations)
02/2015 - 06/2005
5Neoplasms (Cancer)
01/2020 - 09/2002
4Infections
01/2012 - 12/2003
2Autoimmune Diseases (Autoimmune Disease)
01/2016 - 11/2005
2Asthma (Bronchial Asthma)
04/2014 - 11/2013
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
02/2013 - 10/2011
2Pneumonia (Pneumonitis)
07/2011 - 06/2006
2Virus Diseases (Viral Diseases)
01/2011 - 07/2003
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016
1Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2015
1Fibrosis (Cirrhosis)
02/2015
1Lung Injury
02/2015
1Hypertrophy
01/2015
1Bacterial Infections (Bacterial Infection)
11/2014
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2013
1Cholangitis
02/2013
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2012
1Massive Hepatic Necrosis
11/2011
1Hepatitis
11/2011
1Carcinoma (Carcinomatosis)
11/2011
1Pancreatitis
07/2011
1Acute Necrotizing Pancreatitis
07/2011
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
01/2011
1Lyme Disease (Disease, Lyme)
10/2009
1Arthritis (Polyarthritis)
07/2009
1Hyperkalemia
10/2006
1Hypertension (High Blood Pressure)
10/2006
1Pseudohypoaldosteronism
10/2006
1Cytomegalovirus Infections (Inclusion Disease)
02/2006
1Atherosclerotic Plaque (Atheroma)
06/2005
1Atherosclerosis
06/2005
1Crohn Disease (Crohn's Disease)
12/2002
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2002
1Scrapie
05/2002
1Seizures (Absence Seizure)
02/2002

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
01/2020 - 07/2003
5Phosphotransferases (Kinase)IBA
02/2015 - 12/2002
3InflammasomesIBA
01/2012 - 01/2009
3Toll-Like Receptors (Toll-Like Receptor)IBA
10/2009 - 06/2006
2bavachininIBA
04/2014 - 11/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2005 - 12/2002
1Mechanistic Target of Rapamycin Complex 1IBA
01/2020
1Imiquimod (Aldara)FDA LinkGeneric
01/2020
1Mechanistic Target of Rapamycin Complex 2IBA
01/2020
1Protein Tyrosine PhosphatasesIBA
01/2016
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
01/2016
1indium-bleomycinIBA
02/2015
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2015
1Interleukin-13IBA
02/2015
1CollagenIBA
02/2015
1CaspasesIBA
01/2015
1Heme Oxygenase-1IBA
11/2014
1EnzymesIBA
11/2014
1GasotransmittersIBA
11/2014
1Carbon MonoxideIBA
11/2014
1Pharmaceutical PreparationsIBA
04/2014
1Therapeutic UsesIBA
11/2013
1OvalbuminIBA
11/2013
1ChromatinIBA
02/2013
1InterleukinsIBA
02/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2013
1Fc Receptors (Fc Receptor)IBA
01/2012
1teplizumabIBA
01/2012
1Monoclonal AntibodiesIBA
01/2012
1Interleukin-10 (Interleukin 10)IBA
01/2012
1Interleukin-17 (Interleukin 17)IBA
11/2011
1Deubiquitinating EnzymesIBA
11/2011
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
11/2011
1Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
10/2011
1Taurolithocholic AcidIBA
07/2011
1taurolithocholic acid 3-sulfate (TLC-S)IBA
07/2011
1Peptide Hydrolases (Proteases)FDA Link
07/2011
1Proteins (Proteins, Gene)FDA Link
07/2011
1Purinergic Receptors (Receptors, Purine)IBA
07/2011
1CeruletideIBA
07/2011
1Caspase 1 (ICE Protease)IBA
07/2011
1Toll-Like Receptor 9IBA
07/2011
1DNA (Deoxyribonucleic Acid)IBA
01/2011
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2009
1Protein Isoforms (Isoforms)IBA
07/2009
1Immunoglobulin G (IgG)IBA
01/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2009
1Interferon Type IIBA
01/2009
1Apoptosomes (Apoptosome)IBA
01/2008
1Interleukin-6 (Interleukin 6)IBA
06/2005
1NF-kappa B (NF-kB)IBA
06/2005
1CholesterolIBA
06/2005
1NF-KappaB Inhibitor alphaIBA
06/2005
1ChemokinesIBA
12/2003
1InterferonsIBA
07/2003
1Double-Stranded RNA (RNA, Double Stranded)IBA
07/2003
1Cyclin-Dependent Kinases (cdk Proteins)IBA
09/2002
1Lymphotoxin-betaIBA
05/2002
1Lymphotoxin-alpha (Lymphotoxin)IBA
05/2002
1amphiphysinIBA
02/2002

Therapy/Procedure

2Therapeutics
07/2010 - 11/2005
2Transplantation
02/2006 - 05/2002